Singapore-based health analytics platform Biofourmis has raised $100 million in a Series C financing round led by SoftBank Vision Fund 2, per an announcement.
The round also saw the participation of existing investors namely Openspace Ventures, MassMutual Ventures, Sequoia Capital, and EDBI.
